Prostatic artery embolization(PAE) is a minimally invasive operation for the treatment of prostatic hyperplasia and hypertrophy, which can significantly improve urination symptoms and improve the quality of life of patients.The operation is interventional therapy, which is to place the microcatheter in the small prostate artery, block the prostate artery, make the enlarged prostate tissue ischemia, and then atrophy, so as to reduce the size of the prostate, improve urination symptoms.
Market Analysis and Insights: Global Prostatic Arterial Embolization (PAE) Market
The global Prostatic Arterial Embolization (PAE) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prostatic Arterial Embolization (PAE) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Prostatic Arterial Embolization (PAE) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Prostatic Arterial Embolization (PAE) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Prostatic Arterial Embolization (PAE) include Merit Medical Systems, Boston Scientific, Mentice, Siemens Healthineers, Terumo and General Electric, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Prostatic Arterial Embolization (PAE) is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers and Specialty Clinics,, etc. Hospitals provides greatest supports to the Prostatic Arterial Embolization (PAE) industry development. In 2023, global % revenue of Prostatic Arterial Embolization (PAE) went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Prostatic Arterial Embolization (PAE) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostatic Arterial Embolization (PAE), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostatic Arterial Embolization (PAE), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostatic Arterial Embolization (PAE) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostatic Arterial Embolization (PAE) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostatic Arterial Embolization (PAE) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merit Medical Systems
Boston Scientific
Mentice
Siemens Healthineers
Terumo
General Electric
Segment by Type
Guidewires Implantation
Micro Catheters Implantation
Microspheres Implantation
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostatic Arterial Embolization (PAE) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostatic Arterial Embolization (PAE) companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostatic Arterial Embolization (PAE) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostatic Arterial Embolization (PAE) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Guidewires Implantation
1.2.3 Micro Catheters Implantation
1.2.4 Microspheres Implantation
1.3 Market by Application
1.3.1 Global Prostatic Arterial Embolization (PAE) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostatic Arterial Embolization (PAE) Market Perspective (2019-2030)
2.2 Global Prostatic Arterial Embolization (PAE) Growth Trends by Region
2.2.1 Prostatic Arterial Embolization (PAE) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostatic Arterial Embolization (PAE) Historic Market Size by Region (2019-2024)
2.2.3 Prostatic Arterial Embolization (PAE) Forecasted Market Size by Region (2025-2030)
2.3 Prostatic Arterial Embolization (PAE) Market Dynamics
2.3.1 Prostatic Arterial Embolization (PAE) Industry Trends
2.3.2 Prostatic Arterial Embolization (PAE) Market Drivers
2.3.3 Prostatic Arterial Embolization (PAE) Market Challenges
2.3.4 Prostatic Arterial Embolization (PAE) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prostatic Arterial Embolization (PAE) by Players
3.1.1 Global Prostatic Arterial Embolization (PAE) Revenue by Players (2019-2024)
3.1.2 Global Prostatic Arterial Embolization (PAE) Revenue Market Share by Players (2019-2024)
3.2 Global Prostatic Arterial Embolization (PAE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prostatic Arterial Embolization (PAE), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Prostatic Arterial Embolization (PAE) Market Concentration Ratio
3.4.1 Global Prostatic Arterial Embolization (PAE) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostatic Arterial Embolization (PAE) Revenue in 2023
3.5 Global Key Players of Prostatic Arterial Embolization (PAE) Head office and Area Served
3.6 Global Key Players of Prostatic Arterial Embolization (PAE), Product and Application
3.7 Global Key Players of Prostatic Arterial Embolization (PAE), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostatic Arterial Embolization (PAE) Breakdown Data by Type
4.1 Global Prostatic Arterial Embolization (PAE) Historic Market Size by Type (2019-2024)
4.2 Global Prostatic Arterial Embolization (PAE) Forecasted Market Size by Type (2025-2030)
5 Prostatic Arterial Embolization (PAE) Breakdown Data by Application
5.1 Global Prostatic Arterial Embolization (PAE) Historic Market Size by Application (2019-2024)
5.2 Global Prostatic Arterial Embolization (PAE) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostatic Arterial Embolization (PAE) Market Size (2019-2030)
6.2 North America Prostatic Arterial Embolization (PAE) Market Size by Type
6.2.1 North America Prostatic Arterial Embolization (PAE) Market Size by Type (2019-2024)
6.2.2 North America Prostatic Arterial Embolization (PAE) Market Size by Type (2025-2030)
6.2.3 North America Prostatic Arterial Embolization (PAE) Market Share by Type (2019-2030)
6.3 North America Prostatic Arterial Embolization (PAE) Market Size by Application
6.3.1 North America Prostatic Arterial Embolization (PAE) Market Size by Application (2019-2024)
6.3.2 North America Prostatic Arterial Embolization (PAE) Market Size by Application (2025-2030)
6.3.3 North America Prostatic Arterial Embolization (PAE) Market Share by Application (2019-2030)
6.4 North America Prostatic Arterial Embolization (PAE) Market Size by Country
6.4.1 North America Prostatic Arterial Embolization (PAE) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Prostatic Arterial Embolization (PAE) Market Size by Country (2019-2024)
6.4.3 North America Prostatic Arterial Embolization (PAE) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prostatic Arterial Embolization (PAE) Market Size (2019-2030)
7.2 Europe Prostatic Arterial Embolization (PAE) Market Size by Type
7.2.1 Europe Prostatic Arterial Embolization (PAE) Market Size by Type (2019-2024)
7.2.2 Europe Prostatic Arterial Embolization (PAE) Market Size by Type (2025-2030)
7.2.3 Europe Prostatic Arterial Embolization (PAE) Market Share by Type (2019-2030)
7.3 Europe Prostatic Arterial Embolization (PAE) Market Size by Application
7.3.1 Europe Prostatic Arterial Embolization (PAE) Market Size by Application (2019-2024)
7.3.2 Europe Prostatic Arterial Embolization (PAE) Market Size by Application (2025-2030)
7.3.3 Europe Prostatic Arterial Embolization (PAE) Market Share by Application (2019-2030)
7.4 Europe Prostatic Arterial Embolization (PAE) Market Size by Country
7.4.1 Europe Prostatic Arterial Embolization (PAE) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Prostatic Arterial Embolization (PAE) Market Size by Country (2019-2024)
7.4.3 Europe Prostatic Arterial Embolization (PAE) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prostatic Arterial Embolization (PAE) Market Size (2019-2030)
8.2 China Prostatic Arterial Embolization (PAE) Market Size by Type
8.2.1 China Prostatic Arterial Embolization (PAE) Market Size by Type (2019-2024)
8.2.2 China Prostatic Arterial Embolization (PAE) Market Size by Type (2025-2030)
8.2.3 China Prostatic Arterial Embolization (PAE) Market Share by Type (2019-2030)
8.3 China Prostatic Arterial Embolization (PAE) Market Size by Application
8.3.1 China Prostatic Arterial Embolization (PAE) Market Size by Application (2019-2024)
8.3.2 China Prostatic Arterial Embolization (PAE) Market Size by Application (2025-2030)
8.3.3 China Prostatic Arterial Embolization (PAE) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Prostatic Arterial Embolization (PAE) Market Size (2019-2030)
9.2 Asia Prostatic Arterial Embolization (PAE) Market Size by Type
9.2.1 Asia Prostatic Arterial Embolization (PAE) Market Size by Type (2019-2024)
9.2.2 Asia Prostatic Arterial Embolization (PAE) Market Size by Type (2025-2030)
9.2.3 Asia Prostatic Arterial Embolization (PAE) Market Share by Type (2019-2030)
9.3 Asia Prostatic Arterial Embolization (PAE) Market Size by Application
9.3.1 Asia Prostatic Arterial Embolization (PAE) Market Size by Application (2019-2024)
9.3.2 Asia Prostatic Arterial Embolization (PAE) Market Size by Application (2025-2030)
9.3.3 Asia Prostatic Arterial Embolization (PAE) Market Share by Application (2019-2030)
9.4 Asia Prostatic Arterial Embolization (PAE) Market Size by Region
9.4.1 Asia Prostatic Arterial Embolization (PAE) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Prostatic Arterial Embolization (PAE) Market Size by Region (2019-2024)
9.4.3 Asia Prostatic Arterial Embolization (PAE) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Prostatic Arterial Embolization (PAE) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merit Medical Systems
11.1.1 Merit Medical Systems Company Details
11.1.2 Merit Medical Systems Business Overview
11.1.3 Merit Medical Systems Prostatic Arterial Embolization (PAE) Introduction
11.1.4 Merit Medical Systems Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.1.5 Merit Medical Systems Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Prostatic Arterial Embolization (PAE) Introduction
11.2.4 Boston Scientific Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.2.5 Boston Scientific Recent Developments
11.3 Mentice
11.3.1 Mentice Company Details
11.3.2 Mentice Business Overview
11.3.3 Mentice Prostatic Arterial Embolization (PAE) Introduction
11.3.4 Mentice Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.3.5 Mentice Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Prostatic Arterial Embolization (PAE) Introduction
11.4.4 Siemens Healthineers Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.4.5 Siemens Healthineers Recent Developments
11.5 Terumo
11.5.1 Terumo Company Details
11.5.2 Terumo Business Overview
11.5.3 Terumo Prostatic Arterial Embolization (PAE) Introduction
11.5.4 Terumo Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.5.5 Terumo Recent Developments
11.6 General Electric
11.6.1 General Electric Company Details
11.6.2 General Electric Business Overview
11.6.3 General Electric Prostatic Arterial Embolization (PAE) Introduction
11.6.4 General Electric Revenue in Prostatic Arterial Embolization (PAE) Business (2019-2024)
11.6.5 General Electric Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merit Medical Systems
Boston Scientific
Mentice
Siemens Healthineers
Terumo
General Electric
听
听
*If Applicable.
